ABSTRACT NUMBER: ESOC2026A1967 GENETIC PREDICTORS OF ATRIAL NATRIURETIC PEPTIDES AND CIRCULATING BIOMARKERS IN THE CONTEXT OF ETIOLOGICAL DIAGNOSIS OF ISCHEMIC STROKE

Abstract Background and aims Mid-regional pro-atrial natriuretic peptide (MR-proANP) serves as a biomarker for cardioembolic stroke (CES). rs5065, a genetic variant of the Natriuretic Peptide A (NPPA)-gene encoding ANP, remains insufficiently studied in stroke etiologies. Within the PHEGAESUS-study, a phenotype-genotype association study investigating ESUS, we conducted a targeted biomarker analysis to evaluate the impact of rs5065 on MR-proANP and stroke etiology. Methods Between December 2020 and July 2023, patients with ischemic stroke were enrolled at Hannover Medical School. Genotyping was performed using Axiom myDesign Genotyping-Array. MR-proANP serum concentration was measured via fluorescence immunoassay, if samples were available more than 24 hours after stroke onset. Descriptive analyses were performed to elucidate an association between rs5065, MR-proANP-level and ESUS. Results After quality control, 1,003 patients with clinical and SNP-data were available (288 classified as ESUS, 715 as another defined etiology). In the dominant model (AG+GG vs AA), G allele carriers were more frequent in ESUS than in other stroke etiologies (69.1% vs 62.4%, p-chi2: 0.044, OR 1.35, 95%CI: 1.01-1.80). After adjustment for Essen Stroke Risk-Score, the association of rs5065 carrier status with higher odds of ESUS (aOR: 1.37, 95%CI: 1.02-1.84) remained. No differences of MR-proANP-level across the genotypes were observed (median (interquartile range): AG+GG [n=92]: 99.1 (83.8)pmol/l vs AA [n=52]: 91.5 (118.8) pmol/l, p Mann-Whitney-U: 0.8). Conclusions The dominant G allel of rs5065 does not seem to influence MR-proANP-level, but is enriched in ESUS patients. Investigation of NPPA-genomic region may improve better understanding of genetic variances, biomarkers and ESUS. Conflict of interest Rebecca Menkhaus: nothing to disclose, Gerrit M Grosse: nothing to disclose, Johannes Teller: nothing to disclose, Rieke Ringslstetter: nothing to disclose, Maria M Gabriel: nothing to disclose, Vinicius D Gastaldi: nothing to disclose, Hannelore Ehrenreich: nothing to disclose, Karin Weissenborn: nothing to disclose, Anika Grosshennig: nothing to disclose, Johanna Ernst: nothing to disclose

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.921
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1967 GENETIC PREDICTORS OF ATRIAL NATRIURETIC PEPTIDES AND CIRCULATING BIOMARKERS IN THE CONTEXT OF ETIOLOGICAL DIAGNOSIS OF ISCHEMIC STROKE

Gerrit M. Große, Rieke Ringlstetter, Johannes Teller, Karin Weißenborn et al.
European Stroke Journal
Heart Failure Treatment and Management
article

ABSTRACT NUMBER: ESOC2026A1967 GENETIC PREDICTORS OF ATRIAL NATRIURETIC PEPTIDES AND CIRCULATING BIOMARKERS IN THE CONTEXT OF ETIOLOGICAL DIAGNOSIS OF ISCHEMIC STROKE

Gerrit M. Große, Rieke Ringlstetter, Johannes Teller, Karin Weißenborn, Hannelore Ehrenreich, Annika Großhennig, Vinicius Gastaldi, Johanna Ernst, Rebecca Menkhaus, Maria Gabriel
article en

Abstract

Abstract Background and aims Mid-regional pro-atrial natriuretic peptide (MR-proANP) serves as a biomarker for cardioembolic stroke (CES). rs5065, a genetic variant of the Natriuretic Peptide A (NPPA)-gene encoding ANP, remains insufficiently studied in stroke etiologies. Within the PHEGAESUS-study, a phenotype-genotype association study investigating ESUS, we conducted a targeted biomarker analysis to evaluate the impact of rs5065 on MR-proANP and stroke etiology. Methods Between December 2020 and July 2023, patients with ischemic stroke were enrolled at Hannover Medical School. Genotyping was performed using Axiom myDesign Genotyping-Array. MR-proANP serum concentration was measured via fluorescence immunoassay, if samples were available more than 24 hours after stroke onset. Descriptive analyses were performed to elucidate an association between rs5065, MR-proANP-level and ESUS. Results After quality control, 1,003 patients with clinical and SNP-data were available (288 classified as ESUS, 715 as another defined etiology). In the dominant model (AG+GG vs AA), G allele carriers were more frequent in ESUS than in other stroke etiologies (69.1% vs 62.4%, p-chi2: 0.044, OR 1.35, 95%CI: 1.01-1.80). After adjustment for Essen Stroke Risk-Score, the association of rs5065 carrier status with higher odds of ESUS (aOR: 1.37, 95%CI: 1.02-1.84) remained. No differences of MR-proANP-level across the genotypes were observed (median (interquartile range): AG+GG [n=92]: 99.1 (83.8)pmol/l vs AA [n=52]: 91.5 (118.8) pmol/l, p Mann-Whitney-U: 0.8). Conclusions The dominant G allel of rs5065 does not seem to influence MR-proANP-level, but is enriched in ESUS patients. Investigation of NPPA-genomic region may improve better understanding of genetic variances, biomarkers and ESUS. Conflict of interest Rebecca Menkhaus: nothing to disclose, Gerrit M Grosse: nothing to disclose, Johannes Teller: nothing to disclose, Rieke Ringslstetter: nothing to disclose, Maria M Gabriel: nothing to disclose, Vinicius D Gastaldi: nothing to disclose, Hannelore Ehrenreich: nothing to disclose, Karin Weissenborn: nothing to disclose, Anika Grosshennig: nothing to disclose, Johanna Ernst: nothing to disclose

European Stroke JournalVol. 11(Supplement_1)
University of Basel (CH), University Hospital of Basel (CH), Medizinische Hochschule Hannover (DE), Hospital Base (CL), Max Planck Institute for the Study of Religious and Ethnic Diversity (DE), Central Institute of Mental Health (DE), Max Planck Institute of Experimental Medicine (DE), Tissue Dynamics (Israel) (IL)
Good health and well-being
Openalex Percentile: Top 9%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.